Metaphyseal bone dysplasia (BM) is a congenital disease characterized by impaired formation and development of bone metaphyses. As a result of this process, bone growth and development are disrupted, which can lead to various complications and diseases.
DM can be either unilateral or bilateral. It can appear in different parts of the skeleton, for example, in the femur, tibia, humerus, etc.
The main symptom of DM is impaired bone growth. In this case, the bone may grow faster or slower than necessary for its normal development. This leads to deformation of the bone, changing its shape and size.
One of the most common complications of MD is osteoarthritis (OA). OA is a disease that occurs as a result of degenerative changes in the joint. OA can lead to pain, limited movement, and decreased joint function.
Treatment of DM depends on the severity of the disease and its complications. In some cases, surgery may be required to correct bone deformities or remove affected areas. Medications may also be prescribed to improve bone metabolism and prevent the development of osteoporosis.
In general, MD is a serious disease that requires timely diagnosis and treatment. Timely detection and treatment of DM will help prevent the development of complications and maintain normal skeletal function.
Metaphyseal tibial dysplasia (MTD) or multiple metaphyseal dysplasia (MMTD) is a congenital disease that causes underdevelopment of the lower part of the tibia.
It is the most common form of congenital knee deformity. Usually appears in the second year of life